Canada Pension Plan Investment Board’s Supernus Pharmaceuticals SUPN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$823K	Sell	17,700 -1,600	-8%	-$76.8K	﹤0.01%	1077
2026 Q1	$998K	Buy	19,300 +500	+3%	+$25.5K	﹤0.01%	1016
2025 Q4	$934K	Buy	18,800 +16,300	+652%	+$793K	﹤0.01%	1091
2025 Q3	$119K	Sell	2,500 -1,000	-29%	-$40.3K	﹤0.01%	1177
2025 Q2	$110K	Sell	3,500 -3,800	-52%	-$122K	﹤0.01%	1171
2025 Q1	$239K	Buy	7,300 +4,600	+170%	+$163K	﹤0.01%	1032
2024 Q4	$97.6K	Sell	2,700 -59,000	-96%	-$2.08M	﹤0.01%	1255
2024 Q3	$1.92M	Buy	+61,700	New	+$1.93M	﹤0.01%	874
2019 Q2	–	Sell	-88,300	Closed	-$3.09M	–	1464
2019 Q1	$3.09M	Buy	+88,300	New	+$3.29M	0.01%	907

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Canada Pension Plan Investment Board's SUPN Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Supernus Pharmaceuticals (SUPN) stake by 8.3% in Q2 2026, selling an estimated $76.8K and leaving 17,700 shares worth $823K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Canada Pension Plan Investment Board first reported a position in SUPN in Q1 2019 and has held it in 9 quarters since. The position peaked at $3.09M in Q1 2019. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Canada Pension Plan Investment Board held 17,700 shares of Supernus Pharmaceuticals worth $823K as of Q2 2026.
Canada Pension Plan Investment Board sold 1,600 Supernus Pharmaceuticals shares in Q2 2026, an estimated $76.8K.
Supernus Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1077 holding.
Canada Pension Plan Investment Board first reported a position in Supernus Pharmaceuticals in Q1 2019 and has held it in 9 quarters since.
Canada Pension Plan Investment Board's Supernus Pharmaceuticals position peaked at $3.09M in Q1 2019.
334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.